Categories AlphaGraphs, Earnings, Health Care
Infographic: Teva Pharmaceuticals (TEVA) Q1 2020 earnings results
Teva Pharmaceuticals’ (NYSE: TEVA) first quarter 2020 results beat consensus estimates. The drugmaker reported adjusted earnings of $0.76 per share on revenue of $4.4 billion. Wall Street expected Teva to earn $0.59 per share on revenue of $4.15 billion. TEVA stock surged about 7% in the pre-market trading session.
GAAP net income attributable to ordinary shareholders was $69 million or $0.06 per share in the first quarter of 2020, compared to GAAP net loss of $105 million or $0.10 per share in the first quarter of 2019.
[irp posts=”53332″]
The Tel Aviv, Israel-based company confirmed its outlook for fiscal 2020. EPS is expected to be between $2.30 and $2.55, while revenue is targeted to be in the range of $16.6 billion to $17 billion for fiscal 2020.
Most Popular
GIS Earnings: All you need to know about General Mills’ Q1 2025 earnings results
General Mills, Inc. (NYSE: GIS) reported its first quarter 2025 earnings results today. Net sales decreased 1% year-over-year to $4.8 billion. Organic sales were down 1%. Net earnings attributable to
Guardian Pharmacy seeks to raise up to $108 mil in US IPO
Joining the wave of healthcare IPOs this year, amid Fed rate cut expectations, Guardian Pharmacy Services, Inc. is preparing to go public. In a statement filed with the Securities and
Earnings Preview: Will Micron (MU) maintain recovery momentum in Q4?
After recovering from a rough patch, Micron Technology Inc. (NASDAQ: MU) is preparing to report fourth-quarter results next week, even as the market keeps a close watch on the event
